This statistic represents the estimated costs of introducing a new chemical or biological product in the pharmaceutical market from the early 1980s to the 2010s. As of the early 1980s, the costs to bring a new chemical or biological pharmaceutical product to market were at some 180 million U.S. dollars. Some 35 years later, these costs stood at some estimated 3.3 billion U.S. dollars.
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron
CEO, MindShare Germany
Pharma - before the pandemic
Treatments and vaccines
Focus: BioNTech and Moderna
Opinions on COVID-19 vaccines
Business impact
Medtech - before the pandemic
Ventilators and testing
Further related statistics
* For commercial use only
Basic Account
Starter Account
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
